This expert-led session is designed for biotech and pharma teams preparing to move from preclinical promise to clinical reality.

Attendees will gain practical insight into the early decisions that shape successful clinical entry, including regulatory strategy, first-in-human planning, study design considerations and common development pitfalls that can delay progress.

The session will provide an opportunity to hear from experienced clinical and regulatory specialists on how to approach early development with greater clarity, confidence and strategic focus. It will be particularly relevant for organisations planning their next clinical development milestone or seeking to strengthen their pathway from research into the clinic.